Trials / Unknown
UnknownNCT04820608
Transepithelial Customized Cross-linking
Epithelium-on Customized Cross-linking for Keratoconus
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Ophthalmica Eye Institute · Academic / Other
- Sex
- All
- Age
- 12 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Customized remodeled vision (CuRV) is a new corneal cross-linking protocol for keratoconus, combining a transepithelial approach with customized energy application. Our aim is to follow-up our patients and establish the short-and long-term results of CuRV.
Detailed description
Customized remodeled vision is a protocol for oxygen-boosted, tranespithelial cross-linking, customized to apply higher energy at the apex of the cone, relatively lower to the cone area and none to healthy cornea. Thus CuRV promises to halt keratoconus progression, simultaneously offering potential for relatively good visual rehabilitation.Our primary outcomes involve spectacle-corrected distance visual acuity and changes in corneal topography/tomography and OCT parameters. These parameters include Kmax, thinnest corneal pachymetry, maximal anterior and posterior elevation, the Fourier analysis-derived irregularity index, and demarcation line depth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cross-linking | Oxygen-boosted, epithelium-on, customized cross-linking. Highest UV-A application is focused on the apex of the cone. The cone area receives a moderate amount of UV-A, while healthy cornea is spared. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2021-03-29
- Last updated
- 2021-03-29
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT04820608. Inclusion in this directory is not an endorsement.